Non-sterile Medical Washed Abdominal Pad
Non-sterile medical washed abdominal pad
Structure and composition: It is made of 100% cotton gauze by degreasing, bleaching, drying, processing, cutting, folding, sewing and washing.
Product performance: White, soft, non-toxic, odorless, non-fluorescent, no oil spots, no whiskers, no hair corners, no wrinkles or debris adhesion, and has good water absorption performance.
Model specifications: Non-sterile type, washed. The color is mainly white, supplemented by blue and green; it can be sewn according to different requirements. Specifications are divided into 30 * 30CM-4 / 6/8/12, 45 * 45-4 / 6/8/12, 50 * 50-4 / 6/8/12, 30 * 40/40 * 45, etc. Sewing with different requirements.
Packing: 50 / 100PE bag, 5 layers double corrugated kraft paper box.
Scope of application: It is used for one-time use by medical institutions for surgery or protection.
Lap Sponges,Medical Abdominal Swab,Medical Washed Abdominal Pad,Non-Sterile Washed Abdominal Pad Shaoxing Gangfeng Hospital Products Co.,Ltd. , https://www.gangfenggauze.com
The EU's "Traditional Herbal Law" has always been very high on the threshold of traditional Chinese medicine products. The United Kingdom has also been brewing more stringent restrictions on Chinese medicine. The storm began again because of the warning issued by the British Medicines Agency in August about the toxicity of some Chinese medicines that have not been officially registered by the UK.
Experts pointed out that although the attitude of the British market has little impact on the Chinese medicine companies in China, Chinese medicines have to go international in their efforts to standardize.
Pride and Prejudice <br> <br> warned the British and Drug Administration and other products, including Niuhuangjiedu. The warning states that these Chinese medicines contain high levels of harmful toxins such as lead, mercury, and arsenic. Earlier this year, the Canadian Ministry of Health also warned the public not to buy or take medicines such as Tianma headache pills, cataracts, eyesight pills, Tianma pills, and Baifeng pills. The reason is that the content of heavy metals such as mercury and lead is excessive.
Why are Chinese medicines widely accepted by the general public in China often questioned and guarded overseas? Industry insiders pointed out that the Western accusations against Chinese medicine ingredients are not fair. Some ingredients in western medicine are also harmful to human health, but they can play a role in the treatment of certain diseases and doctors can accept these ingredients. However, in their opinion, food standards should be used for botanicals. Once they contain similar ingredients, they are toxic and unacceptable.
"The oncology drugs in western medicine have a lot of side effects, but they have been used a lot in chemotherapy," said Huang Jianyin, the deputy secretary-general of the World Federation of Traditional Chinese Medicine. "Angong Niuhuang Pills have an obvious effect on the treatment of stroke encephalitis, but their ingredients contain cinnabar, if Measured by Western standards, the mercury level must be exceeded."
Xu Ming, vice president of the Medical Insurance Association, also expressed similar views: “Some countries' drug administrations are skeptical about traditional Chinese medicine because they have not yet accepted the Chinese medicine culture.†Xu Ming said that Chinese medicine pays attention to the compatibility of various drugs with the use of foreign countries. It is difficult for people to understand and accept such concepts as "phase to be", "together", "intimate", and "killing each other."
Respondents who do not hurt the bones <br> <br> agreed that the impact of the ban on the sale of the UK Chinese enterprises is not large. According to the data provided by the Medicare Chamber of Commerce, the total amount of Chinese proprietary Chinese medicine sold to the United Kingdom last year was approximately US$1.62 million, and the United Kingdom ranked 19th among all overseas markets. Therefore, the market’s attitude has limited impact on domestic TCM companies. Yu Zhibin, deputy director of the Department of Medicinal Products of the Medicare Chamber of Commerce, made several comparisons to reporters:
First of all, the main market for Chinese medicine in China. In 2012, the total overseas sales of Chinese patent medicines in China was 260 million U.S. dollars. Compared with the total domestic sales of more than 80 billion U.S. dollars, it was "not on a heavyweight level." Second, the UK accounted for a relatively small proportion in overseas sales of Chinese medicines. In general, the total amount of Chinese medicines entering the US and Southeast Asian markets is more than that of the European Union; even in EU member states, the United Kingdom sets the strictest standards for the sales of Chinese medicines; finally, the total exports of Chinese patent medicines are smaller than those of medicinal herbs. . "At present, there are 764 domestic enterprises that have proprietary Chinese medicines export business. The total sales in the UK market are not large, and they are distributed to a number of companies. Each has a smaller sales volume, so it won't have much impact," Yu Zhibin said.
Although the direct impact is not great, this British practice once again shows the difficulties of internationalization of Chinese medicine. "Chinese medicine must speed up the pace of 'going out', must speed up standardization, and establish scientific, international standards in terms of toxicology, side effects, etc.," said Huang Jianyin.
According to the EU's current "Traditional Herbal Law," Chinese medicine imported into the European Union must prove to be safe for application in EU member states for more than 15 years, and at the same time apply in third countries for more than 30 years before it can be formally registered. The procedures required are complicated and the cost is high. "Scared back" a lot of Chinese pharmaceutical companies interested in "sea".